Molecular Methods
Nucleic acid-based technologies to detect and quantify DNA, RNA, and gene expression, including tissue mRNA analysis, biodistribution of nucleic acid-based therapeutics, and ddPCR- and qPCR-based approaches.
Analytical support integrating molecular, protein-, and cell-based methods for biologics, mRNA therapeutics, vaccines, and translational research, from early discovery to advanced preclinical studies.
We provide bioanalytical services supporting biologics, mRNA therapeutics, vaccines, and translational research projects. Our platform combines complementary molecular, protein-, and cell-based methods:
Nucleic acid-based technologies to detect and quantify DNA, RNA, and gene expression, including tissue mRNA analysis, biodistribution of nucleic acid-based therapeutics, and ddPCR- and qPCR-based approaches.
Immunological, biochemical, and cellular technologies to measure protein levels, antibody responses, immune cell function, and biomarkers, including ELISA, multiplex cytokine analysis, and ELISpot.
Reproducible, study-specific workflows across a broad range of biological matrices and species, from rodents and large animals to non-GLP clinical samples. Available standalone or combined with in vivo studies.
Gene expression analysis for biologics, mRNA therapeutics, and translational research. Molecular and cellular technologies are combined to quantify nucleic acids, detect biomarkers, and profile tissue-specific expression in preclinical studies.
Analytical workflows for mRNA therapeutics and vaccines, from biodistribution studies to immune profiling. Molecular, protein-, and cell-based assays evaluate expression, pharmacodynamics, and biological activity in preclinical models.
Quantification of proteins, antibodies, and signaling pathways for biologics development, biomarker research, and translational studies. Reproducible platforms allow detection and monitoring across a broad range of biological matrices.
Multiplex cytokine analysis to characterize inflammatory and immune responses in preclinical and translational studies. Protein- and RNA-based approaches quantify cytokines, immune activation markers, and tissue-specific inflammatory profiles.
Preclinical vaccination studies and analytical support for vaccine research, with particular expertise in mRNA-based platforms. The service covers characterization of humoral and cellular immune responses for vaccine optimization, efficacy assessment, and proof-of-concept studies.
Reporter-based assessment of biodistribution, transgene expression, and functional activity of mRNA and gene therapy candidates. In vivo and in vitro approaches allow longitudinal monitoring and quantitative assessment of reporter gene activity.
Tell us what you need and we will prepare a quote for your project.
PDF · Direct download after providing a few details